These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32700809)

  • 1. A comprehensive individual patient data meta-analysis of the effects of cardiac contractility modulation on functional capacity and heart failure-related quality of life.
    Giallauria F; Cuomo G; Parlato A; Raval NY; Kuschyk J; Stewart Coats AJ
    ESC Heart Fail; 2020 Oct; 7(5):2922-2932. PubMed ID: 32700809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: an individual patient's data meta-analysis of randomized controlled trials.
    Giallauria F; Vigorito C; Piepoli MF; Stewart Coats AJ
    Int J Cardiol; 2014 Aug; 175(2):352-7. PubMed ID: 24975782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of cardiac contractility modulation in heart failure : A meta-analysis of clinical trials.
    Liu X; Yang HJ; Ping HQ; Qiu S; Shi S; Yang B
    Herz; 2017 Dec; 42(8):766-775. PubMed ID: 28101624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: A preliminary report.
    Kloppe A; Mijic D; Schiedat F; Bogossian H; Mügge A; Rousso B; Lemke B
    Cardiol J; 2016; 23(1):114-9. PubMed ID: 26503077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, Performance, and Efficacy of Cardiac Contractility Modulation Delivered by the 2-Lead Optimizer Smart System: The FIX-HF-5C2 Study.
    Wiegn P; Chan R; Jost C; Saville BR; Parise H; Prutchi D; Carson PE; Stagg A; Goldsmith RL; Burkhoff D
    Circ Heart Fail; 2020 Apr; 13(4):e006512. PubMed ID: 32264716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis.
    Taylor RS; Walker S; Ciani O; Warren F; Smart NA; Piepoli M; Davos CH
    Health Technol Assess; 2019 May; 23(25):1-98. PubMed ID: 31140973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation.
    Abraham WT; Kuck KH; Goldsmith RL; Lindenfeld J; Reddy VY; Carson PE; Mann DL; Saville B; Parise H; Chan R; Wiegn P; Hastings JL; Kaplan AJ; Edelmann F; Luthje L; Kahwash R; Tomassoni GF; Gutterman DD; Stagg A; Burkhoff D; Hasenfuß G
    JACC Heart Fail; 2018 Oct; 6(10):874-883. PubMed ID: 29754812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure.
    Borggrefe MM; Lawo T; Butter C; Schmidinger H; Lunati M; Pieske B; Misier AR; Curnis A; Böcker D; Remppis A; Kautzner J; Stühlinger M; Leclerq C; Táborsky M; Frigerio M; Parides M; Burkhoff D; Hindricks G
    Eur Heart J; 2008 Apr; 29(8):1019-28. PubMed ID: 18270213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Cardiac Contractility Modulation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Mando R; Goel A; Habash F; Saad M; Ayoub K; Vallurupalli S; Maskoun W
    Cardiovasc Ther; 2019; 2019():9769724. PubMed ID: 31772622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction.
    Müller D; Remppis A; Schauerte P; Schmidt-Schweda S; Burkhoff D; Rousso B; Gutterman D; Senges J; Hindricks G; Kuck KH
    Clin Res Cardiol; 2017 Nov; 106(11):893-904. PubMed ID: 28685207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac contractility modulation for heart failure: a meta-analysis of randomized controlled trials.
    Kwong JS; Sanderson JE; Yu CM
    Pacing Clin Electrophysiol; 2012 Sep; 35(9):1111-8. PubMed ID: 22734676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study.
    Pappone C; Augello G; Rosanio S; Vicedomini G; Santinelli V; Romano M; Agricola E; Maggi F; Buchmayr G; Moretti G; Mika Y; Ben-Haim SA; Wolzt M; Stix G; Schmidinger H
    J Cardiovasc Electrophysiol; 2004 Apr; 15(4):418-27. PubMed ID: 15089990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT).
    Kuschyk J; Nägele H; Heinz-Kuck K; Butter C; Lawo T; Wietholt D; Roeger S; Gutterman D; Burkhoff D; Rousso B; Borggrefe M
    Int J Cardiol; 2019 Feb; 277():173-177. PubMed ID: 30409733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SGLT2 Inhibitors, Functional Capacity, and Quality of Life in Patients With Heart Failure: A Systematic Review and Meta-Analysis.
    Gao M; Bhatia K; Kapoor A; Badimon J; Pinney SP; Mancini DM; Santos-Gallego CG; Lala A
    JAMA Netw Open; 2024 Apr; 7(4):e245135. PubMed ID: 38573633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter ablation versus medical rate control for persistent atrial fibrillation in patients with heart failure: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials.
    Zhu M; Zhou X; Cai H; Wang Z; Xu H; Chen S; Chen J; Xu X; Xu H; Mao W
    Medicine (Baltimore); 2016 Jul; 95(30):e4377. PubMed ID: 27472728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of cardiac contractility modulation in heart failure treatment.
    Chinyere IR; Balakrishnan M; Hutchinson MD
    Curr Opin Cardiol; 2022 Jan; 37(1):30-35. PubMed ID: 34698667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac contractility modulation in heart failure patients: Randomized comparison of signal delivery through one vs. two ventricular leads.
    Röger S; Said S; Kloppe A; Lawo T; Emig U; Rousso B; Gutterman D; Borggrefe M; Kuschyk J
    J Cardiol; 2017 Jan; 69(1):326-332. PubMed ID: 27590412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial).
    Anker SD; Coats AJ; Cristian G; Dragomir D; Pusineri E; Piredda M; Bettari L; Dowling R; Volterrani M; Kirwan BA; Filippatos G; Mas JL; Danchin N; Solomon SD; Lee RJ; Ahmann F; Hinson A; Sabbah HN; Mann DL
    Eur Heart J; 2015 Sep; 36(34):2297-309. PubMed ID: 26082085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure: A Meta-analysis of Randomized Controlled Trials.
    Turagam MK; Garg J; Whang W; Sartori S; Koruth JS; Miller MA; Langan N; Sofi A; Gomes A; Choudry S; Dukkipati SR; Reddy VY
    Ann Intern Med; 2019 Jan; 170(1):41-50. PubMed ID: 30583296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of drug and exercise intervention on functional capacity and quality of life in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.
    Fukuta H; Goto T; Wakami K; Ohte N
    Eur J Prev Cardiol; 2016 Jan; 23(1):78-85. PubMed ID: 25520380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.